Guillain-Barré and Miller Fisher syndromes occurring with tumor necrosis factor α antagonist therapy-Reference-Cited by-同舟云学术

Guillain-Barré and Miller Fisher syndromes occurring with tumor necrosis factor α antagonist therapy

Published:2006 Issue:5 Volume:54 Page:1429-1434
ISSN:0004-3591
Container-title:Arthritis & Rheumatism
language:en
Short-container-title:Arthritis Rheum

Author:

Shin In-Sook J.,Baer Alan N.,Kwon Hyon J.,Papadopoulos Elektra J.,Siegel Jeffrey N.

Publisher

Wiley

Subject

Pharmacology (medical),Immunology,Rheumatology,Immunology and Allergy

Reference16 articles.

1. Demyelination occurring during anti-tumor necrosis factor ? therapy for inflammatory arthritides

2. US Food and Drug Administration. Arthritis Advisory Committee Briefing Document. URL: http://www.fda.gov/ohrms/dockets/ac/03/briefing/3930B1_04_A-Centocor-Remicade%20.pdf.

3. Neuropathy resembling CIDP in patients receiving tumor necrosis factor- blockers

4. Successful rechallenge with anti-tumor necrosis factor α for psoriatic arthritis after development of demyelinating nervous system disease during initial treatment: Comment on the article by Mohan et al

Cited by 169 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of Uveitis Patients on Anti-TNF Agents Who Develop Demyelinating Disease – A Case Series;Journal of Ophthalmic Inflammation and Infection;2024-07-30

2. The spectrum of anti-GQ1B antibody syndrome: beyond Miller Fisher syndrome and Bickerstaff brainstem encephalitis;Neurological Sciences;2024-07-11

3. Case report and brief literature review: possible association of secukinumab with Guillain–Barré syndrome in psoriasis;Frontiers in Immunology;2024-06-28

4. Anti‐TNF‐α drug‐induced lupus presenting with cutaneous vasculitis and mononeuritis multiplex;International Journal of Rheumatic Diseases;2024-06

5. Guillain-Barré Syndrome in a Patient Receiving Anti-Tumor Necrosis Factor for Crohn Disease: Coincidence or Consequence?;American Journal of Case Reports;2024-04-09